The $1.5m UConn Innovation Fund, established in August last year, has made its first three investments, namely Torigen Pharmaceuticals, Bioarray Genetics and Shoreline Biome.
Connecticut University (UConn) made its first three investments through the $1.5m UConn Innovation Fund, also backed by state-owned investment firm Connecticut Innovations (CI) and financial services firm Webster Bank, on Friday.
The three businesses are all participants in the UConn Technology Incubation Program, a prerequisite to be awarded capital from the fund.
They are Torigen Pharmaceuticals, which is developing veterinary cancer care therapies, Bioarray Genetics, which is using molecular diagnostics to improve the prediction of patient response to cancer treatments,…
